Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of June 8, 2025 • 6:00 PM ET

Date/Time Source News Release
05/14/2025 04:05 PM EDT GlobeNewswire Inhibikase Therapeutics Announces First Quarter 2025 Financial Results and Highlights Recent Activity
04/14/2025 08:00 AM EDT GlobeNewswire Inhibikase Therapeutics Announces Appointment of David McIntyre as Chief Financial Officer
03/27/2025 04:01 PM EDT GlobeNewswire Inhibikase Therapeutics Announces 2024 Financial Results and Highlights Recent Activity
02/24/2025 08:00 AM EST GlobeNewswire Inhibikase Announces Expansion of Senior Leadership Team
02/18/2025 08:00 AM EST GlobeNewswire Inhibikase Appoints Industry Veteran Mark Iwicki as CEO to Drive Next Stage of Company's Growth
11/14/2024 08:37 AM EST GlobeNewswire Inhibikase Therapeutics Reports Third Quarter Financial Results and Highlights Recent Activity
10/21/2024 09:05 AM EDT GlobeNewswire Inhibikase Therapeutics Announces Closing of up to $275 Million Financing and Advancement of IkT-001Pro into a Late Stage Clinical Trial in Pulmonary Arterial Hypertension
10/09/2024 09:18 AM EDT GlobeNewswire Inhibikase Therapeutics Announces Pricing of $110 Million Private Placement to Advance IkT-001Pro, an Optimized Prodrug of Imatinib, into a Late-Stage Trial in Pulmonary Arterial Hypertension
08/14/2024 04:25 PM EDT GlobeNewswire Inhibikase Therapeutics Reports Second Quarter Financial Results and Highlights Recent Period Activity
08/07/2024 08:00 AM EDT GlobeNewswire Inhibikase Therapeutics to Report Second Quarter 2024 Financial Results on August 14, 2024
Page

Additional News

As of June 8, 2025 • 6:00 PM ET

Date/Time Source News Release
05/16/2025 05:30 AM EDT US Earnings Reports Expected earnings - Inhibikase Therapeutics Inc.
05/15/2025 11:56 AM EDT SeekingAlpha Inhibikase Therapeutics GAAP EPS of -$0.15
05/02/2025 05:07 AM EDT SeekingAlpha Inhibikase Therapeutics: A Hold With Uncertain Prospects In PAH
04/14/2025 08:19 AM EDT SeekingAlpha Inhibikase Therapeutics appoints David McIntyre as CFO; shares rise
03/27/2025 05:04 PM EDT SeekingAlpha Inhibikase Therapeutics GAAP EPS of -$1.16
03/26/2025 07:00 AM EDT US Earnings Reports Expected US Company Earnings on Wednesday, March 26th, 2025
03/26/2025 05:30 AM EDT US Earnings Reports Expected earnings - Inhibikase Therapeutics Inc.
03/05/2025 09:55 AM EST Zacks Inhibikase Therapeutics (IKT) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now
01/13/2025 08:10 AM EST Investing News Network Top 5 Small-cap Pharma Stocks of 2025 (Updated January 2025)
11/27/2024 04:30 AM EST US Earnings Reports Expected earnings - Inhibikase Therapeutics Inc.
Page

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.